)
Visual
earnings real time
Biovica International (BIOVIC) investor relations material
Biovica International Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary18 Dec, 2025
Executive summary
DiviTum, a blood-based test for monitoring breast cancer treatment efficacy, is FDA-cleared, CE-marked, included in Medicare, and has demonstrated strong clinical value, with new studies confirming its utility in metastatic breast cancer.
The product targets both metastatic and early breast cancer, with market potential in the hundreds of millions of dollars, and is offered as a service in the U.S. and as kits in other markets.
Clinical trials, collaborations with leading academic centers, and commercial agreements with major US cancer centers underpin commercialization and expansion.
Rights and directed share issues in August raised SEK 122.3 million before costs, significantly strengthening liquidity.
The Board has suspended financial targets due to sales delays and pipeline unpredictability, but aims for positive cash flow by 2027.
Financial highlights
Q2 sales reached SEK 2.7 million, up 16% year-over-year; year-to-date sales were SEK 5.3 million, up 31%.
U.S. IVD business grew 47% and pharma business 24% in Q2; research test business nearly doubled.
Operating loss for Q2 was SEK -14,964 thousand, improved from SEK -19,753 thousand year-over-year.
Cash and cash equivalents at period end were SEK 100.6 million, up from SEK 61.9 million.
Equity ratio at 89% versus 80% last year.
Outlook and guidance
Ambition to achieve cash flow positivity in 2027 remains, though timing is now expected later in the year due to partnership delays.
No specific revenue targets provided; updates will follow after closing key agreements.
Pharma Services pipeline is strong, with SEK 25–28 million in contracts over the next three years and expected record revenues in coming quarters.
U.S. clinical sales growth has flattened but is expected to rebound with new client bill agreements and adjuvant product rollouts.
Sales targets for FY 2025/26 and 2026/27 withdrawn due to delays in US clinical study and sales pipeline maturation.
Impact of new NCI commercial agreement
Pharma Services revenue recognition timeline
Potential capital from TO4 B warrants
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Biovica International earnings date
Q3 202618 Mar, 2026
Next Biovica International earnings date
Q3 202618 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Biovica International AB, a biotechnology company, develops and commercializes blood-based biomarker assays that enhance the monitoring of cancer therapies and predict patient outcome. The company's focus is on prediction of treatment efficacy and prognosis, thereby providing physicians with objective decision-making tools that enable informed treatment choice. The company is based in Uppsala, Sweden.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage